FRED MOLL

Fred Moll stands as a towering figure in the medical technology landscape, renowned for his visionary leadership, entrepreneurial spirit, and profound impact on surgical innovation. As the Managing Partner at Sonder Capital, he continues to shape the future of healthcare by identifying and nurturing the next generation of disruptive medical companies. Sonder Capital, under Moll's guidance, is a venture capital firm dedicated to investing in early-stage medical technology, robotics, and digital health enterprises that promise to revolutionize patient care and clinical practice.

At Sonder Capital, Fred Moll's investment focus is sharply honed on areas where technology can create significant advancements. This includes cutting-edge medical devices, sophisticated surgical robotics, transformative digital health platforms, and innovative life science solutions. His approach is not merely financial; he brings decades of operational experience, strategic insight, and a deep understanding of regulatory pathways to the portfolio companies. This hands-on mentorship is invaluable for startups navigating the complex healthcare industry, helping them accelerate development and achieve market penetration.

Moll's illustrious career background is a testament to his pioneering spirit. He is perhaps best known as the co-founder of Intuitive Surgical, the company behind the groundbreaking da Vinci Surgical System. This invention single-handedly ushered in the era of robotic-assisted minimally invasive surgery, dramatically improving patient outcomes and expanding surgical possibilities worldwide. His entrepreneurial journey didn't stop there; he later founded Auris Health, which developed the Monarch Platform for robotic bronchoscopy, further extending the reach of robotics into diagnostic and therapeutic procedures within the lungs. Auris Health was subsequently acquired by Johnson & Johnson, a clear validation of Moll's ability to build and scale highly successful medical technology companies.

His transition from serial entrepreneur to venture capitalist with Sonder Capital was a natural evolution. Having built and exited multiple successful ventures, Moll now leverages his unparalleled experience to empower other innovators. He understands the challenges and opportunities inherent in bringing novel medical technologies to market, from concept and development to clinical trials and commercialization. This unique perspective allows Sonder Capital to make strategic investments in companies with the potential for significant clinical impact and strong commercial viability.

Fred Moll's influence extends beyond individual company successes. He has consistently pushed the boundaries of what's possible in healthcare, driven by a commitment to improving patient lives through technological innovation. Through Sonder Capital, he continues to champion advancements that promise to make surgery safer, diagnostics more precise, and healthcare more accessible and efficient. His ongoing dedication ensures that the legacy of innovation he started decades ago will continue to thrive, fostering a healthier future for all.